Back

Does DAPT-score provide personalized medicine in clinical practice for avoiding bleeding and thrombotic events ?

30 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Thrombosis and antithrombotic in acute coronary syndrome Antithrombotic agents ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Raisuke Iijima

Toho University, Tokyo (Japan)

24 More presentations in this session

Presentation thumbnail
Assistant Professor G. Alonso Salinas (Pamplona, ES)
Abstract
Presentation thumbnail
Mr J. Allonen (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Professor S. Obradovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Professor I. Seljeflot (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor H. Yagasaki (Gifu, JP)
Abstract

Access the full session

Session thumbnail
Poster session 7 - Thrombosis and antithrombotic in acute coronary syndrome

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.
31 August 2019
thumbnail
Congress Presentation
Pharmacodynamic effects of vorapaxar as an add-on antiplatelet therapy in patients with and without diabetes mellitus: the optimizing anti-platelet therapy in diabetes mellitus (OPTIMUS)-5 study
1 September 2019
thumbnail
Congress Presentation
Practical value and external validation of the PRECISE-DAPT cancer score in patients with acute myocardial infarction
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources